Reported relationships
Latest disclosed role at each company.
No relationships currently tracked through insider filings.
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
No balances currently tracked through insider filings.
Past disclosures · reporting ended (1)
No longer tracked through insider filings. These historical balances do not imply present ownership or a zero position.
Health Catalyst, Inc.
Report date June 01, 2026 · Filed June 03, 2026
Section 16 reporting ended · disclosed 2026-06-03. Current position is not established by this disclosure.
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 321,132 |
Reported balance
After 2026-06-01 transaction · row 1
1 source rowRow 1 · 2026-06-01 · Tax withholding · Disposed 8,519 · Balance 321,132 F1: Represents the number of shares required to be sold by the Reporting Person to cover tax withholding obligations in connection with the vesting of Issuer's Restricted Stock Units. This sale is mandated by the Issuer's election under its equity incentive plans to require the satisfaction of tax withholding obligations to be funded by a "sell to cover" transaction and does not represent a discretionary trade by the Reporting Person. |
Filing footnotes · ownership attribution and instrument terms
F1: Represents the number of shares required to be sold by the Reporting Person to cover tax withholding obligations in connection with the vesting of Issuer's Restricted Stock Units. This sale is mandated by the Issuer's election under its equity incentive plans to require the satisfaction of tax withholding obligations to be funded by a "sell to cover" transaction and does not represent a discretionary trade by the Reporting Person.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| July 15, 2022 Filed Jul 20, 2022 20:05 UTC | Health Catalyst, Inc. HCAT · Entity 1565 | SaleCommon Stock | 648 | $16.06 | $10,406.88 |
DisclosureSEC source: 0001562180-22-005729 · primarydocument.xml · nonDerivative · entry 1 Llewelyn Linda · CIK 0001780878 · Chief People Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 58,029 F1 · kind: The sale reported on this Form 4 was made pursuant to a written trading plan adopted by the Reporting Person in accordance with Rule 10b5-1. Read SEC document |
| June 15, 2022 Filed Jun 16, 2022 20:58 UTC | Health Catalyst, Inc. HCAT · Entity 1565 | SaleCommon Stock | 648 | $12.20 | $7,905.60 |
DisclosureSEC source: 0001562180-22-005151 · primarydocument.xml · nonDerivative · entry 1 Llewelyn Linda · CIK 0001780878 · Chief People Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 58,677 F1 · kind: The sale reported on this Form 4 was made pursuant to a written trading plan adopted by the Reporting Person in accordance with Rule 10b5-1. Read SEC document |
| June 01, 2022 Filed Jun 3, 2022 21:46 UTC | Health Catalyst, Inc. HCAT · Entity 1565 | Tax withholdingCommon Stock | 30 | $14.95 | $448.57 |
DisclosureSEC source: 0001562180-22-004818 · primarydocument.xml · nonDerivative · entry 2 Llewelyn Linda · CIK 0001780878 · Chief People Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 59,325 F1 · kind: Represents the number of shares required to be sold by the Reporting Person to cover tax withholding obligations in connection with the vesting of Issuer's Restricted Stock Units. This sale is mandated by the Issuer's election under its equity incentive plans to require the satisfaction of tax withholding obligations to be funded by a "sell to cover" transaction and does not represent a discretionary trade by the Reporting Person. F3 · price: Represents the weighted average sale price of the shares sold ranging from $14.91 to $15.07 per share, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in Footnotes (2) and (3). Read SEC document |
| June 01, 2022 Filed Jun 3, 2022 21:46 UTC | Health Catalyst, Inc. HCAT · Entity 1565 | Tax withholdingCommon Stock | 818 | $14.24 | $11,645.95 |
DisclosureSEC source: 0001562180-22-004818 · primarydocument.xml · nonDerivative · entry 1 Llewelyn Linda · CIK 0001780878 · Chief People Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 59,355 F1 · kind: Represents the number of shares required to be sold by the Reporting Person to cover tax withholding obligations in connection with the vesting of Issuer's Restricted Stock Units. This sale is mandated by the Issuer's election under its equity incentive plans to require the satisfaction of tax withholding obligations to be funded by a "sell to cover" transaction and does not represent a discretionary trade by the Reporting Person. F2 · price: Represents the weighted average sale price of the shares sold ranging from $13.91 to $14.90 per share, inclusive. Read SEC document |
| May 16, 2022 Filed May 18, 2022 23:47 UTC | Health Catalyst, Inc. HCAT · Entity 1565 | SaleCommon Stock | 1,860 | $15.87 | $29,518.20 |
DisclosureSEC source: 0001562180-22-004222 · primarydocument.xml · nonDerivative · entry 1 Llewelyn Linda · CIK 0001780878 · Chief People Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 60,173 F1 · kind: The sale reported on this Form 4 was made pursuant to a written trading plan adopted by the Reporting Person in accordance with Rule 10b5-1. Read SEC document |
| April 18, 2022 Filed Apr 21, 2022 23:10 UTC | Health Catalyst, Inc. HCAT · Entity 1565 | SaleCommon Stock | 200 | $23.21 | $4,642.00 |
DisclosureSEC source: 0001562180-22-003506 · primarydocument.xml · nonDerivative · entry 2 Llewelyn Linda · CIK 0001780878 · Chief People Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 62,033 F1 · kind: The sale reported on this Form 4 was made pursuant to a written trading plan adopted by the Reporting Person in accordance with Rule 10b5-1. Read SEC document |
| April 18, 2022 Filed Apr 21, 2022 23:10 UTC | Health Catalyst, Inc. HCAT · Entity 1565 | SaleCommon Stock | 1,839 | $22.52 | $41,407.84 |
DisclosureSEC source: 0001562180-22-003506 · primarydocument.xml · nonDerivative · entry 1 Llewelyn Linda · CIK 0001780878 · Chief People Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 62,233 F1 · kind: The sale reported on this Form 4 was made pursuant to a written trading plan adopted by the Reporting Person in accordance with Rule 10b5-1. F2 · price: Represents the weighted average sale price of the shares sold ranging from $22.14 to $22.92 per share, inclusive. The Reporting Person will provide, upon request by the Issuer, a security holder of the Issuer, or the staff of the Securities and Exchange Commission, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. Read SEC document |
| March 15, 2022 Filed Mar 17, 2022 21:42 UTC | Health Catalyst, Inc. HCAT · Entity 1565 | SaleCommon Stock | 2,039 | $21.08 | $42,984.16 |
DisclosureSEC source: 0001562180-22-002751 · primarydocument.xml · nonDerivative · entry 1 Llewelyn Linda · CIK 0001780878 · Chief People Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 64,072 F1 · kind: The sale reported on this Form 4 was made pursuant to a written trading plan adopted by the Reporting Person in accordance with Rule 10b5-1. Read SEC document |
| March 03, 2022 Filed Mar 7, 2022 23:21 UTC | Health Catalyst, Inc. HCAT · Entity 1565 | SaleCommon Stock | 218 | $26.89 | $5,861.63 |
DisclosureSEC source: 0001562180-22-002417 · primarydocument.xml · nonDerivative · entry 1 Llewelyn Linda · CIK 0001780878 · Chief People Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 66,111 F1 · kind: The sale reported on this Form 4 was made pursuant to a written trading plan adopted by the Reporting Person in accordance with Rule 10b5-1. Read SEC document |
| March 02, 2022 Filed Mar 4, 2022 00:36 UTC | Health Catalyst, Inc. HCAT · Entity 1565 | Tax withholdingCommon Stock | 198 | $26.69 | $5,284.88 |
DisclosureSEC source: 0001562180-22-002344 · primarydocument.xml · nonDerivative · entry 3 Llewelyn Linda · CIK 0001780878 · Chief People Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 66,329 F1 · kind: Represents the number of shares required to be sold by the Reporting Person to cover tax withholding obligations in connection with the vesting of Issuer's Restricted Stock Units. This sale is mandated by the Issuer's election under its equity incentive plans to require the satisfaction of tax withholding obligations to be funded by a "sell to cover" transaction and does not represent a discretionary trade by the Reporting Person. F4 · price: Represents the weighted average sale price of the shares sold ranging from $25.29 to $27.56 per share, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in Footnotes (2) and (4). Read SEC document |
| March 01, 2022 Filed Mar 4, 2022 00:36 UTC | Health Catalyst, Inc. HCAT · Entity 1565 | GrantCommon Stock | 1,861 | $0.00 | $0.00 |
DisclosureSEC source: 0001562180-22-002344 · primarydocument.xml · nonDerivative · entry 2 Llewelyn Linda · CIK 0001780878 · Chief People Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 66,527 F3 · shares: Represents an award of 1,861 performance-based restricted units ("PRSUs") pursuant to the Issuer's 2019 Stock Option and Incentive Plan (the "2019 Plan"). Each PRSU represents a contingent right to receive one share of the Issuer's common stock. Subject to the terms of the 2019 Plan and Issuer's satisfaction of certain performance criteria for the fiscal year ended December 31, 2021, the PRSUs noted above vested on March 1, 2022. Read SEC document |
| March 01, 2022 Filed Mar 4, 2022 00:36 UTC | Health Catalyst, Inc. HCAT · Entity 1565 | Tax withholdingCommon Stock | 1,216 | $26.63 | $32,382.93 |
DisclosureSEC source: 0001562180-22-002344 · primarydocument.xml · nonDerivative · entry 1 Llewelyn Linda · CIK 0001780878 · Chief People Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 64,666 F1 · kind: Represents the number of shares required to be sold by the Reporting Person to cover tax withholding obligations in connection with the vesting of Issuer's Restricted Stock Units. This sale is mandated by the Issuer's election under its equity incentive plans to require the satisfaction of tax withholding obligations to be funded by a "sell to cover" transaction and does not represent a discretionary trade by the Reporting Person. F2 · price: Represents the weighted average sale price of the shares sold ranging from $26.23 to $27.44 per share, inclusive. Read SEC document |
| February 24, 2022 Filed Mar 1, 2022 02:24 UTC | Health Catalyst, Inc. HCAT · Entity 1565 | GrantCommon Stock | 35,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001562180-22-002021 · primarydocument.xml · nonDerivative · entry 1 Llewelyn Linda · CIK 0001780878 · Chief People Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 65,882 F1 · shares: Represents an award of restricted stock units ("RSUs") granted pursuant to the Issuer's 2019 Stock Option and Incentive Plan (the "2019 Plan"). Each RSU represents a contingent right to receive one share of the Issuer's common stock. Subject to the terms of the 2019 Plan, 25% of the RSUs will vest on December 1, 2022 and, thereafter, the remaining 75% of the RSUs will vest in 12 equal quarterly installments. Read SEC document |
| February 01, 2022 Filed Feb 3, 2022 22:30 UTC | Health Catalyst, Inc. HCAT · Entity 1565 | Exercise / conversionStock Option (Right to Buy) · Derivative | 1,100 | $0.00 Strike: $10.80 | $0.00 |
DisclosureSEC source: 0001562180-22-001075 · primarydocument.xml · derivative · entry 3 Llewelyn Linda · CIK 0001780878 · Chief People Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 5,820 Underlying: Common Stock · 1,100 shares Expires 2028-09-27 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_date: 25% of the 59,351 shares underlying the options vested in an annual installment on September 25, 2019 and the remaining balance vested or will vest in equal monthly installments until the option vests in full on September 25, 2022. Read SEC document |
| February 01, 2022 Filed Feb 3, 2022 22:30 UTC | Health Catalyst, Inc. HCAT · Entity 1565 | SaleCommon Stock | 1,100 | $30.00 | $33,000.00 |
DisclosureSEC source: 0001562180-22-001075 · primarydocument.xml · nonDerivative · entry 2 Llewelyn Linda · CIK 0001780878 · Chief People Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 30,882 F1 · kind: The sales reported on this Form 4 was made pursuant to a written trading plan adopted by the Reporting Person on December 9, 2020, in accordance with Rule 10b5-1. Read SEC document |
| February 01, 2022 Filed Feb 3, 2022 22:30 UTC | Health Catalyst, Inc. HCAT · Entity 1565 | Exercise / conversionCommon Stock | 1,100 | $10.80 | $11,880.00 |
DisclosureSEC source: 0001562180-22-001075 · primarydocument.xml · nonDerivative · entry 1 Llewelyn Linda · CIK 0001780878 · Chief People Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 31,982 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| January 04, 2022 Filed Jan 7, 2022 02:07 UTC | Health Catalyst, Inc. HCAT · Entity 1565 | Exercise / conversionStock Option (Right to Buy) · Derivative | 2,050 | $0.00 Strike: $10.80 | $0.00 |
DisclosureSEC source: 0001562180-22-000329 · primarydocument.xml · derivative · entry 5 Llewelyn Linda · CIK 0001780878 · Chief People Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 6,920 Underlying: Common Stock · 950 shares Expires 2028-09-27 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · derivative.exercise_date: 25% of the 59,351 shares underlying the options vested in an annual installment on September 25, 2019 and the remaining balance vested or will vest in equal monthly installments until the option vests in full on September 25, 2022. Read SEC document |
| January 04, 2022 Filed Jan 7, 2022 02:07 UTC | Health Catalyst, Inc. HCAT · Entity 1565 | Exercise / conversionStock Option (Right to Buy) · Derivative | 1,100 | $0.00 Strike: $11.78 | $0.00 |
DisclosureSEC source: 0001562180-22-000329 · primarydocument.xml · derivative · entry 4 Llewelyn Linda · CIK 0001780878 · Chief People Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 4,754 Underlying: Common Stock · 1,100 shares Expires 2028-01-24 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_date: 25% of the 17,954 shares underlying the options vested in an annual installment on January 24, 2019 and the remaining balance vested or will vest in equal monthly installments until the option vests in full on January 24, 2022. Read SEC document |
| January 04, 2022 Filed Jan 7, 2022 02:07 UTC | Health Catalyst, Inc. HCAT · Entity 1565 | SaleCommon Stock | 3,234 | $40.23 | $130,103.82 |
DisclosureSEC source: 0001562180-22-000329 · primarydocument.xml · nonDerivative · entry 3 Llewelyn Linda · CIK 0001780878 · Chief People Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 30,882 F1 · kind: The sale reported on this Form 4 was made pursuant to a written trading plan adopted by the Reporting Person on December 9, 2020, in accordance with Rule 10b5-1. Read SEC document |
| January 04, 2022 Filed Jan 7, 2022 02:07 UTC | Health Catalyst, Inc. HCAT · Entity 1565 | Exercise / conversionCommon Stock | 1,100 | $11.78 | $12,958.00 |
DisclosureSEC source: 0001562180-22-000329 · primarydocument.xml · nonDerivative · entry 2 Llewelyn Linda · CIK 0001780878 · Chief People Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 34,116 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| January 04, 2022 Filed Jan 7, 2022 02:07 UTC | Health Catalyst, Inc. HCAT · Entity 1565 | Exercise / conversionCommon Stock | 2,050 | $10.80 | $22,140.00 |
DisclosureSEC source: 0001562180-22-000329 · primarydocument.xml · nonDerivative · entry 1 Llewelyn Linda · CIK 0001780878 · Chief People Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 33,016 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| December 06, 2021 Filed Dec 7, 2021 21:14 UTC | Health Catalyst, Inc. HCAT · Entity 1565 | SaleCommon Stock | 743 | $37.61 | $27,946.83 |
DisclosureSEC source: 0001562180-21-007533 · primarydocument.xml · nonDerivative · entry 8 Llewelyn Linda · CIK 0001780878 · Chief People Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 30,966 F3 · kind: The sale reported on this Form 4 was made pursuant to a written trading plan adopted by the Reporting Person on December 9, 2020, in accordance with Rule 10b5-1. F7 · price: Represents the weighted average sale price of the shares sold ranging from $37.45 to $38.17 per share, inclusive. The Reporting Person will provide, upon request by the Issuer, a security holder of the Issuer, or the staff of the Securities and Exchange Commission, full information regarding the number of shares sold at each separate price within the range set forth in Footnotes (4) - (7). Read SEC document |
| December 03, 2021 Filed Dec 7, 2021 21:14 UTC | Health Catalyst, Inc. HCAT · Entity 1565 | Exercise / conversionStock Option (Right to Buy) · Derivative | 1,100 | $0.00 Strike: $10.80 | $0.00 |
DisclosureSEC source: 0001562180-21-007533 · primarydocument.xml · derivative · entry 10 Llewelyn Linda · CIK 0001780878 · Chief People Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 23,498 Underlying: Common Stock · 1,100 shares Expires 2028-09-27 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F9 · derivative.exercise_date: 25% of the 59,351 shares underlying the options vested in an annual installment on September 25, 2019 and the remaining balance vested or will vest in equal monthly installments until the option vests in full on September 25, 2022. Read SEC document |
| December 03, 2021 Filed Dec 7, 2021 21:14 UTC | Health Catalyst, Inc. HCAT · Entity 1565 | Exercise / conversionStock Option (Right to Buy) · Derivative | 1,100 | $0.00 Strike: $11.78 | $0.00 |
DisclosureSEC source: 0001562180-21-007533 · primarydocument.xml · derivative · entry 9 Llewelyn Linda · CIK 0001780878 · Chief People Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 5,854 Underlying: Common Stock · 1,100 shares Expires 2028-01-24 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F8 · derivative.exercise_date: 25% of the 17,954 shares underlying the options vested in an annual installment on January 24, 2019 and the remaining balance vested or will vest in equal monthly installments until the option vests in full on January 24, 2022. Read SEC document |
| December 03, 2021 Filed Dec 7, 2021 21:14 UTC | Health Catalyst, Inc. HCAT · Entity 1565 | SaleCommon Stock | 1,100 | $42.87 | $47,157.00 |
DisclosureSEC source: 0001562180-21-007533 · primarydocument.xml · nonDerivative · entry 7 Llewelyn Linda · CIK 0001780878 · Chief People Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 31,709 F3 · kind: The sale reported on this Form 4 was made pursuant to a written trading plan adopted by the Reporting Person on December 9, 2020, in accordance with Rule 10b5-1. Read SEC document |
| December 03, 2021 Filed Dec 7, 2021 21:14 UTC | Health Catalyst, Inc. HCAT · Entity 1565 | SaleCommon Stock | 200 | $41.56 | $8,312.00 |
DisclosureSEC source: 0001562180-21-007533 · primarydocument.xml · nonDerivative · entry 6 Llewelyn Linda · CIK 0001780878 · Chief People Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 32,809 F3 · kind: The sale reported on this Form 4 was made pursuant to a written trading plan adopted by the Reporting Person on December 9, 2020, in accordance with Rule 10b5-1. F6 · price: Represents the weighted average sale price of the shares sold ranging from $41.53 to $41.59 per share, inclusive. Read SEC document |
| December 03, 2021 Filed Dec 7, 2021 21:14 UTC | Health Catalyst, Inc. HCAT · Entity 1565 | SaleCommon Stock | 500 | $40.30 | $20,152.00 |
DisclosureSEC source: 0001562180-21-007533 · primarydocument.xml · nonDerivative · entry 5 Llewelyn Linda · CIK 0001780878 · Chief People Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 33,009 F3 · kind: The sale reported on this Form 4 was made pursuant to a written trading plan adopted by the Reporting Person on December 9, 2020, in accordance with Rule 10b5-1. F5 · price: Represents the weighted average sale price of the shares sold ranging from $40.05 to $40.62 per share, inclusive. Read SEC document |
| December 03, 2021 Filed Dec 7, 2021 21:14 UTC | Health Catalyst, Inc. HCAT · Entity 1565 | SaleCommon Stock | 400 | $39.20 | $15,681.00 |
DisclosureSEC source: 0001562180-21-007533 · primarydocument.xml · nonDerivative · entry 4 Llewelyn Linda · CIK 0001780878 · Chief People Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 33,509 F3 · kind: The sale reported on this Form 4 was made pursuant to a written trading plan adopted by the Reporting Person on December 9, 2020, in accordance with Rule 10b5-1. F4 · price: Represents the weighted average sale price of the shares sold ranging from $38.90 to $39.74 per share, inclusive. Read SEC document |
| December 03, 2021 Filed Dec 7, 2021 21:14 UTC | Health Catalyst, Inc. HCAT · Entity 1565 | Exercise / conversionCommon Stock | 1,100 | $10.80 | $11,880.00 |
DisclosureSEC source: 0001562180-21-007533 · primarydocument.xml · nonDerivative · entry 3 Llewelyn Linda · CIK 0001780878 · Chief People Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 33,909 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| December 03, 2021 Filed Dec 7, 2021 21:14 UTC | Health Catalyst, Inc. HCAT · Entity 1565 | Exercise / conversionCommon Stock | 1,100 | $11.78 | $12,958.00 |
DisclosureSEC source: 0001562180-21-007533 · primarydocument.xml · nonDerivative · entry 2 Llewelyn Linda · CIK 0001780878 · Chief People Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 32,809 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| December 02, 2021 Filed Dec 7, 2021 21:14 UTC | Health Catalyst, Inc. HCAT · Entity 1565 | Tax withholdingCommon Stock | 2,839 | $41.95 | $119,088.95 |
DisclosureSEC source: 0001562180-21-007533 · primarydocument.xml · nonDerivative · entry 1 Llewelyn Linda · CIK 0001780878 · Chief People Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 31,709 F1 · kind: Represents the number of shares required to be sold by the Reporting Person to cover tax withholding obligations in connection with the vesting of Issuer's Restricted Stock Units. This sale is mandated by the Issuer's election under its equity incentive plans to require the satisfaction of tax withholding obligations to be funded by a "sell to cover" transaction and does not represent a discretionary trade by the Reporting Person. F2 · price: Represents a weighted average price reported by the broker. These shares were sold as part of a block trade in multiple transactions at prices ranging from $40.33 to $42.76, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote with regard to the block trade. Read SEC document |
| November 01, 2021 Filed Nov 2, 2021 20:30 UTC | Health Catalyst, Inc. HCAT · Entity 1565 | Exercise / conversionStock Option (Right to Buy) · Derivative | 2,200 | $0.00 Strike: $10.80 | $0.00 |
DisclosureSEC source: 0001562180-21-006757 · primarydocument.xml · derivative · entry 6 Llewelyn Linda · CIK 0001780878 · Chief People Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 24,598 Underlying: Common Stock · 2,200 shares Expires 2028-09-27 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F5 · derivative.exercise_date: 25% of the 59,351 shares underlying the options vested in an annual installment on September 25, 2019 and the remaining balance vested or will vest in equal monthly installments until the option vests in full on September 25, 2022. Read SEC document |
| November 01, 2021 Filed Nov 2, 2021 20:30 UTC | Health Catalyst, Inc. HCAT · Entity 1565 | Exercise / conversionStock Option (Right to Buy) · Derivative | 1,100 | $0.00 Strike: $11.78 | $0.00 |
DisclosureSEC source: 0001562180-21-006757 · primarydocument.xml · derivative · entry 5 Llewelyn Linda · CIK 0001780878 · Chief People Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 6,954 Underlying: Common Stock · 1,100 shares Expires 2028-01-24 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F4 · derivative.exercise_date: 25% of the 17,954 shares underlying the options vested in an annual installment on January 24, 2019 and the remaining balance vested or will vest in equal monthly installments until the option vests in full on January 24, 2022. Read SEC document |
| November 01, 2021 Filed Nov 2, 2021 20:30 UTC | Health Catalyst, Inc. HCAT · Entity 1565 | SaleCommon Stock | 600 | $54.08 | $32,449.02 |
DisclosureSEC source: 0001562180-21-006757 · primarydocument.xml · nonDerivative · entry 4 Llewelyn Linda · CIK 0001780878 · Chief People Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 34,548 F1 · kind: The sales reported on this Form 4 was made pursuant to a written trading plan adopted by the Reporting Person on December 9, 2020, in accordance with Rule 10b5-1. F3 · price: Represents the weighted average sale price of the shares sold ranging from $54.06 to $54.15 per share, inclusive. The Reporting Person will provide, upon request by the Issuer, a security holder of the Issuer, or the staff of the Securities and Exchange Commission, full information regarding the number of shares sold at each separate price within the range set forth in Footnotes (2) and (3). Read SEC document |
| November 01, 2021 Filed Nov 2, 2021 20:30 UTC | Health Catalyst, Inc. HCAT · Entity 1565 | SaleCommon Stock | 2,700 | $53.49 | $144,415.98 |
DisclosureSEC source: 0001562180-21-006757 · primarydocument.xml · nonDerivative · entry 3 Llewelyn Linda · CIK 0001780878 · Chief People Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 35,148 F1 · kind: The sales reported on this Form 4 was made pursuant to a written trading plan adopted by the Reporting Person on December 9, 2020, in accordance with Rule 10b5-1. F2 · price: Represents the weighted average sale price of the shares sold ranging from $53.05 to $54.03 per share, inclusive. Read SEC document |
| November 01, 2021 Filed Nov 2, 2021 20:30 UTC | Health Catalyst, Inc. HCAT · Entity 1565 | Exercise / conversionCommon Stock | 1,100 | $11.78 | $12,958.00 |
DisclosureSEC source: 0001562180-21-006757 · primarydocument.xml · nonDerivative · entry 2 Llewelyn Linda · CIK 0001780878 · Chief People Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 37,848 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| November 01, 2021 Filed Nov 2, 2021 20:30 UTC | Health Catalyst, Inc. HCAT · Entity 1565 | Exercise / conversionCommon Stock | 2,200 | $10.80 | $23,760.00 |
DisclosureSEC source: 0001562180-21-006757 · primarydocument.xml · nonDerivative · entry 1 Llewelyn Linda · CIK 0001780878 · Chief People Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 36,748 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| October 01, 2021 Filed Oct 6, 2021 00:01 UTC | Health Catalyst, Inc. HCAT · Entity 1565 | Exercise / conversionStock Option (Right to Buy) · Derivative | 950 | $0.00 Strike: $10.80 | $0.00 |
DisclosureSEC source: 0001562180-21-006325 · primarydocument.xml · derivative · entry 6 Llewelyn Linda · CIK 0001780878 · Chief People Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 26,798 Underlying: Common Stock · 950 shares Expires 2028-09-27 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F4 · derivative.exercise_date: 25% of the 59,351 shares underlying the options vested in an annual installment on September 25, 2019 and the remaining balance vested or will vest in equal monthly installments until the option vests in full on September 25, 2022. Read SEC document |
| October 01, 2021 Filed Oct 6, 2021 00:01 UTC | Health Catalyst, Inc. HCAT · Entity 1565 | Exercise / conversionStock Option (Right to Buy) · Derivative | 2,200 | $0.00 Strike: $11.78 | $0.00 |
DisclosureSEC source: 0001562180-21-006325 · primarydocument.xml · derivative · entry 5 Llewelyn Linda · CIK 0001780878 · Chief People Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 8,054 Underlying: Common Stock · 2,200 shares Expires 2028-01-24 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · derivative.exercise_date: 25% of the 17,954 shares underlying the options vested in an annual installment on January 24, 2019 and the remaining balance vested or will vest in equal monthly installments until the option vests in full on January 24, 2022. Read SEC document |
| October 01, 2021 Filed Oct 6, 2021 00:01 UTC | Health Catalyst, Inc. HCAT · Entity 1565 | SaleCommon Stock | 2,200 | $49.20 | $108,241.98 |
DisclosureSEC source: 0001562180-21-006325 · primarydocument.xml · nonDerivative · entry 4 Llewelyn Linda · CIK 0001780878 · Chief People Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 34,548 F1 · kind: The sales reported on this Form 4 was made pursuant to a written trading plan adopted by the Reporting Person on December 9, 2020, in accordance with Rule 10b5-1. F2 · price: Represents the weighted average sale price of the shares sold ranging from $48.76 to $49.69 per share, inclusive. The Reporting Person will provide, upon request by the Issuer, a security holder of the Issuer, or the staff of the Securities and Exchange Commission, full information regarding the number of shares sold at each separate price within the range set forth in this Footnote. Read SEC document |
| October 01, 2021 Filed Oct 6, 2021 00:01 UTC | Health Catalyst, Inc. HCAT · Entity 1565 | SaleCommon Stock | 1,059 | $50.01 | $52,960.59 |
DisclosureSEC source: 0001562180-21-006325 · primarydocument.xml · nonDerivative · entry 3 Llewelyn Linda · CIK 0001780878 · Chief People Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 36,748 F1 · kind: The sales reported on this Form 4 was made pursuant to a written trading plan adopted by the Reporting Person on December 9, 2020, in accordance with Rule 10b5-1. Read SEC document |
| October 01, 2021 Filed Oct 6, 2021 00:01 UTC | Health Catalyst, Inc. HCAT · Entity 1565 | Exercise / conversionCommon Stock | 950 | $10.80 | $10,260.00 |
DisclosureSEC source: 0001562180-21-006325 · primarydocument.xml · nonDerivative · entry 2 Llewelyn Linda · CIK 0001780878 · Chief People Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 37,807 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| October 01, 2021 Filed Oct 6, 2021 00:01 UTC | Health Catalyst, Inc. HCAT · Entity 1565 | Exercise / conversionCommon Stock | 2,200 | $11.78 | $25,916.00 |
DisclosureSEC source: 0001562180-21-006325 · primarydocument.xml · nonDerivative · entry 1 Llewelyn Linda · CIK 0001780878 · Chief People Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 36,857 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| September 03, 2021 Filed Sep 8, 2021 20:08 UTC | Health Catalyst, Inc. HCAT · Entity 1565 | Exercise / conversionStock Option (Right to Buy) · Derivative | 1,100 | $0.00 Strike: $10.80 | $0.00 |
DisclosureSEC source: 0001562180-21-005871 · primarydocument.xml · derivative · entry 5 Llewelyn Linda · CIK 0001780878 · Chief People Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 27,748 Underlying: Common Stock · 1,100 shares Expires 2028-09-27 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F4 · derivative.exercise_date: 25% of the 59,351 shares underlying the options vested in an annual installment on September 25, 2019 and the remaining balance vested or will vest in equal monthly installments until the option vests in full on September 25, 2022. Read SEC document |
| September 03, 2021 Filed Sep 8, 2021 20:08 UTC | Health Catalyst, Inc. HCAT · Entity 1565 | Exercise / conversionStock Option (Right to Buy) · Derivative | 1,100 | $0.00 Strike: $11.78 | $0.00 |
DisclosureSEC source: 0001562180-21-005871 · primarydocument.xml · derivative · entry 4 Llewelyn Linda · CIK 0001780878 · Chief People Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 10,254 Underlying: Common Stock · 1,100 shares Expires 2028-01-24 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · derivative.exercise_date: 25% of the 17,954 shares underlying the options vested in an annual installment on January 24, 2019 and the remaining balance vested or will vest in equal monthly installments until the option vests in full on January 24, 2022. Read SEC document |
| September 03, 2021 Filed Sep 8, 2021 20:08 UTC | Health Catalyst, Inc. HCAT · Entity 1565 | SaleCommon Stock | 3,179 | $54.27 | $172,522.10 |
DisclosureSEC source: 0001562180-21-005871 · primarydocument.xml · nonDerivative · entry 3 Llewelyn Linda · CIK 0001780878 · Chief People Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 34,657 F1 · kind: The sale reported on this Form 4 was made pursuant to a written trading plan adopted by the Reporting Person on December 9, 2020, in accordance with Rule 10b5-1. F2 · price: Represents the weighted average sale price of the shares sold ranging from $53.86 to $54.66 per share, inclusive. The Reporting Person will provide, upon request by the Issuer, a security holder of the Issuer, or the staff of the Securities and Exchange Commission, full information regarding the number of shares sold at each separate price within the range set forth in this Footnote. Read SEC document |
| September 03, 2021 Filed Sep 8, 2021 20:08 UTC | Health Catalyst, Inc. HCAT · Entity 1565 | Exercise / conversionCommon Stock | 1,100 | $10.80 | $11,880.00 |
DisclosureSEC source: 0001562180-21-005871 · primarydocument.xml · nonDerivative · entry 2 Llewelyn Linda · CIK 0001780878 · Chief People Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 37,836 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| September 03, 2021 Filed Sep 8, 2021 20:08 UTC | Health Catalyst, Inc. HCAT · Entity 1565 | Exercise / conversionCommon Stock | 1,100 | $11.78 | $12,958.00 |
DisclosureSEC source: 0001562180-21-005871 · primarydocument.xml · nonDerivative · entry 1 Llewelyn Linda · CIK 0001780878 · Chief People Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 36,736 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| September 01, 2021 Filed Sep 3, 2021 20:06 UTC | Health Catalyst, Inc. HCAT · Entity 1565 | Tax withholdingCommon Stock | 475 | $54.23 | $25,760.25 |
DisclosureSEC source: 0001562180-21-005801 · primarydocument.xml · nonDerivative · entry 1 Llewelyn Linda · CIK 0001780878 · Chief People Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 35,636 F1 · kind: Represents the number of shares required to be sold by the Reporting Person to cover tax withholding obligations in connection with the vesting of Issuer's Restricted Stock Units. This sale is mandated by the Issuer's election under its equity incentive plans to require the satisfaction of tax withholding obligations to be funded by a "sell to cover" transaction and does not represent a discretionary trade by the Reporting Person. F2 · price: Represents a weighted average price. These shares were sold by the Reporting Person in multiple transactions at prices ranging from $53.91 to $54.76, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this Footnote. Read SEC document |
| August 02, 2021 Filed Aug 4, 2021 20:29 UTC | Health Catalyst, Inc. HCAT · Entity 1565 | Exercise / conversionStock Option (Right to Buy) · Derivative | 1,100 | $0.00 Strike: $10.80 | $0.00 |
DisclosureSEC source: 0001562180-21-005166 · primarydocument.xml · derivative · entry 7 Llewelyn Linda · CIK 0001780878 · Chief People Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 28,848 Underlying: Common Stock · 1,100 shares Expires 2028-09-27 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F4 · derivative.exercise_date: 25% of the 59,351 shares underlying the options vested in an annual installment on September 25, 2019 and the remaining balance vested or will vest in equal monthly installments until the option vests in full on September 25, 2022. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.